Curcumin-reduced gold nanoparticles facilitate IL-12 delivery to a cervical cancer in vitro cell model

Nanomedicine (Lond). 2023 Jun;18(13):945-960. doi: 10.2217/nnm-2023-0076. Epub 2023 Jul 28.

Abstract

Aim: To synthesize curcumin-reduced gold nanoparticles (AuNPs) for the efficient delivery to and expression of the IL-12 gene in cervical cancer (HeLa) cells in vitro. Methods: Curcumin-reduced AuNPs were synthesized, stabilized with poly-L-lysine and PEG, conjugated to IL-12 DNA and physicochemically characterized. Cytotoxicity and IL-12 expression were accessed in vitro. Results & discussion: Stable, spherical AuNPs effectively compacted and protected the IL-12 DNA and tolerated well in vitro. Real-time quantitative PCR and ELISA confirmed the successful delivery and expression of the IL-12 gene in HeLa cells. Conclusion: The favorable attributes of this AuNP-delivery system and the significant IL-12 expression obtained augur well for cytokine-based therapy or immunotherapy in cervical cancer.

Keywords: IL-12; cervical cancer; gene therapy; gold nanoparticles; immunotherapy; nanomedicine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Curcumin* / chemistry
  • DNA
  • Female
  • Gold / chemistry
  • HeLa Cells
  • Humans
  • Interleukin-12* / genetics
  • Interleukin-12* / pharmacology
  • Metal Nanoparticles* / chemistry
  • Uterine Cervical Neoplasms* / drug therapy

Substances

  • Curcumin
  • DNA
  • Gold
  • Interleukin-12